The first IOL, implanted in 1949, was made of polymethyl methacrylate (PMMA). It is a rigid, nonfoldable material with less than 1% water content.So the safety and stability of the PMMA have been verified. Penetration by aqueous humor has been noted to cause small vacuoles within the lens optic. This “glistening” phenomenon is rarely seen with rigid PMMA IOL.

Rigid Polymethyl Methacrylate (PMMA) IOL Design features:

1- The IOL produced by our company is made of PMMA, allowing the good flexibility of the loops,which can be bent to the optical part of the IOL, making the IOL implanted easily inside the capsular bag.

2- The 10°angle of the haptic allows the lens to have a complete contact with the posterior side of the lens capsule.

3- The thin edge of the IOL reduces the edge glare in a large degree.

4- The haptic are designed to maintain stability of lens implant in the eye, which keeps the IOL centered in the optical field.

5- The IOL produced by our company can filter the ultraviolet rays effectively, and the rate of the visible light is greater than 90%.

Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. was founded in 1991, is one of the first enterprises in China to produce intraocular lenses and related products. It has introduced advanced American technology and established a complete automated production line, integrating R&D, production, and sales. After 30 years of development, it has become China A benchmark enterprise in the field of intraocular lenses.

Till now, our company has products in sale, such as PMMA Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma Drainage Implants, Hydroxypropyl Methylcellulose, Sodium Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in 1991, with very low incidences of adverse effects and serious adverse events.

The highest eminence is to be gianed step by step.  Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. will work hard and innovate constantly to improve the quantity of products, elevate the core competitiveness of the enterprise and make even greater contribution to the human health undertaking.